Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to develop and validate a clinical outcome measure to evaluate disability and disease progression of children 3 years of age and younger (infants and toddlers) with various types of Charcot-Marie-Tooth disease (CMT).


Clinical Trial Description

Most forms of CMT begin in childhood and progress throughout a person's lifetime. Current research suggests that treatment to slow disease progression may be most effective if introduced early in a patient's life before muscle weakness and sensation loss develop, as it may be easier to slow disease progression than to reverse disability that is already in place. Clinical outcome measures have been developed for adults (CMT Neuropathy Score) and for children 3 years of age and older (CMT Pediatric Scale). However, no CMT-specific clinical outcome measure currently exists to measure disease severity or progression in children from birth to 3 years of age. It is the goal of this study to develop and validate the CMT Infant Scale (CMTInfS) to meet this need. ;


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02979145
Study type Observational
Source Sydney Children's Network
Contact
Status Recruiting
Phase N/A
Start date October 2016

See also
  Status Clinical Trial Phase
Recruiting NCT06203093 - Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for iPSC Generation and Biobanking
Recruiting NCT03782883 - The Impact of Charcot-Marie-Tooth Disease in the Real World
Terminated NCT03254199 - A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps. Phase 2
Completed NCT02011204 - Study of Electrical Impedance Myography (EIM) in ALS N/A
Completed NCT00149045 - Follow up and Observation of Charcot Marie Tooth Disease in Families N/A
Completed NCT04786522 - Irisin Levels in Patients With Charcot-Marie-Tooth (CMT) Disease
Recruiting NCT05011006 - NT-3 Levels and Function in Individuals With CMT
Recruiting NCT05902351 - Natural History Study for Charcot Marie Tooth Disease
Terminated NCT03943290 - Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX) Phase 2
Active, not recruiting NCT04762758 - Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients Phase 3
Completed NCT02788734 - Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies N/A
Recruiting NCT02532244 - Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
Terminated NCT05827419 - Hearing and Balance Disorders in Peripheral Neuropathy
Terminated NCT03124459 - Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease Phase 2
Terminated NCT03810508 - A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J)
Recruiting NCT04010188 - A Registered Cohort Study on Charcot-Marie-Tooth Disease
Completed NCT00271635 - Ascorbic Acid Treatment in CMT1A Trial (AATIC) Phase 2
Completed NCT03715283 - Change in MUNIX in Patients With CMT1A Undergoing a Home Ankle Strengthening Program Versus Standard of Care N/A
Completed NCT02001038 - Survey of Current Management of Orthopaedic Complications in CMT Patients N/A
Not yet recruiting NCT01289704 - Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A) Phase 2/Phase 3